Search filters

List of works by Ana Maria Gonzalez-Angulo

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers

scientific article

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer

scientific article

A new hypothesis for the cancer mechanism ⬇️

scientific article published on June 1, 2012

A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer

scientific article published on 17 October 2011

A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer

scientific article

A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients

scientific article published in January 2014

A systems approach to analysis of molecular complexity in breast cancer

scientific article published on January 2009

AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer

scientific article

Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer

scientific article

Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes

scientific article published on September 2015

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients ⬇️

scientific article published on September 28, 2010

Adjuvant Systemic Therapies in Breast Cancer ⬇️

scientific article published on 08 February 2013

Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast

scientific article published on November 2007

Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer.

scientific article published on September 2006

Advances and future directions in the targeting of HER2-positive breast cancer: implications for the future.

scientific article published on March 2014

Advances in triple receptor-negative breast cancer.

scientific article

Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer

scientific article published on 05 July 2011

Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype

scientific article

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

scientific article published on August 2008

Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit

scientific article

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer

scientific article published on 10 March 2009

Antibody-based vaccines for the treatment of melanoma

scientific article

Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy

scientific article published on 16 October 2015

Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma

scientific article published on December 2006

Biomarker discordance pre and post neoadjuvant chemotherapy in breast cancer

scientific article published on January 2012

Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer ⬇️

scientific article published on August 29, 2012

Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer.

scientific article

Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

scientific article published on 10 January 2006

Brain metastases and breast cancer subtypes

scientific article published on 19 March 2010

Breast Cancer Biomarkers: Utility in Clinical Practice

scientific article published on December 2013

Breast cancer and metastasis: on the way toward individualized therapy

scientific article published on September 1, 2012

Breast cancer diagnosis during pregnancy

scientific article published on May 2009

Breast cancer in 2012: New drugs, new knowledge, new targets

scientific article published on 08 January 2013

Breast cancer multifocality and multicentricity and locoregional recurrence

scientific article published on 17 October 2013

Breast cancer subtype and baseline characteristics from diabetic breast cancer patients are not different from nondiabetics.

scientific article

Breast carcinoma with neuroendocrine differentiation and myocardial metastases

scientific article published on 01 December 2007

Case Control Study of Women Treated With Chemotherapy for Breast Cancer During Pregnancy as Compared With Nonpregnant Patients With Breast Cancer ⬇️

scientific article published on April 10, 2013

Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment

scientific article published on 01 October 2004

Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications

scientific article

Classification of Ipsilateral Breast Tumor Recurrences After Breast Conservation Therapy Can Predict Patient Prognosis and Facilitate Treatment Planning ⬇️

scientific article published on March 1, 2011

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

scientific article published on September 2008

Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival

scientific article published on December 2007

Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer

scientific article published on 27 January 2014

Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer.

scientific article published on 13 August 2016

Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors

scientific article

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy

scientific article published on 3 December 2007

Concordance of genomic alterations between primary and recurrent breast cancer.

scientific article

Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

scientific article published on 05 December 2018

Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes

scientific article published on 8 March 2016

Cyclooxygenase 2 inhibitors and colon cancer ⬇️

scientific article published on January 1, 2002

Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis

scientific article

Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer ⬇️

scientific article published on December 6, 2012

Defining prognosis for women with breast cancer and CNS metastases by HER2 status

scientific article published on 11 March 2008

Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.

scientific article

Development of new cancers in patients with DCIS: the M.D. Anderson experience

scientific article published on 28 November 2007

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes

scientific article published on 02 December 2013

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early

scientific article published on 29 November 2010

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

scientific article published on 15 August 2013

Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy

scientific article published on 01 March 2006

Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer

scientific article published on 01 October 2006

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.

scientific article published on 23 July 2014

Earlier age of onset of BRCA mutation-related cancers in subsequent generations

scientific article

Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer

scientific article

Effect of CYP2D6 polymorphisms on breast cancer recurrence ⬇️

scientific article published on August 5, 2011

Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.

scientific article

Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer ⬇️

scientific article published on July 28, 2011

Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel

scientific article published on 12 May 2016

Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience

scientific article published on September 2007

Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline‐ and nonanthracycline‐based regimens for HER2‐positive breast cancer ⬇️

scientific article published on September 27, 2011

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer

scientific article published on 07 January 2014

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts

scientific article

Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer

scientific article published on 14 May 2010

Evaluating Breast Cancer Risk With Genome-Wide Association Studies: Is This Approach Patient Ready? ⬇️

scientific article published on October 29, 2012

Everolimus in the treatment of hormone receptor-positive breast cancer

scientific article published on 20 September 2012

Expanding the arsenal: metformin for the treatment of triple-negative breast cancer?

scientific article

Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer

scientific article published on 09 March 2007

Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy

scientific article

Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer

scientific article

Functional consequence of the MET-T1010I polymorphism in breast cancer

scientific article published on February 2015

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer

scientific article

Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy.

scientific article published on 8 November 2012

Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy

scientific article published on 07 August 2013

Future of personalized medicine in oncology: a systems biology approach

scientific article

Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer ⬇️

scientific article published on January 10, 2012

Genotype inBRCA-associated Breast Cancers ⬇️

scientific article published on December 10, 2012

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

scientific article published on 28 April 2007

HER2 testing: current status and future directions.

scientific article published on 11 September 2013

HER2-neu positivity in patients with small and node-negative breast cancer (pT1a,b,N0,M0): a high risk group?

scientific article published on September 2009

High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients

scientific article

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller

scientific article

High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients

scientific article

Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.

scientific article published on 29 July 2008

Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer

scientific article published on 17 April 2012

Hormone receptor-positive breast cancer: the known and the unknown

scientific article published on August 1, 2012

Identifying factors that impact survival among women with inflammatory breast cancer

scientific article published on 15 July 2011

Ifosfamide-induced encephalopathy.

scientific article published in October 2002

Impact of Body Mass Index on Survival Outcome Among Women With Early Stage Triple-Negative Breast Cancer ⬇️

scientific article published on 01 October 2012

Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer ⬇️

scientific article published on April 1, 2011

Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy

scientific article published in February 2013

Impact of clinical trial on survival outcomes

scientific article published on 16 August 2016

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers ⬇️

scientific article published on August 11, 2011

Implications of functional proteomics in breast cancer

scientific article published on 24 March 2014

Importance of accurate HER2 testing in patients with metastatic breast cancer

scientific article published on 01 December 2010

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

scientific article

Incidence of brain metastases as a first site of recurrence among women with triple receptor–negative breast cancer ⬇️

scientific article published on February 22, 2012

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

scientific article published on 10 February 2007

Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics

scientific article published on 01 December 2005

Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease

scientific article published on 01 October 2007

Inflammatory breast cancer and high-dose chemotherapy: back to the past

scientific article published on 01 June 2005

Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings

scientific article published on 26 July 2007

Influence of biospecimen variables on proteomic biomarkers in breast cancer

scientific article

Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes ⬇️

scientific article published on September 18, 2012

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

scientific article published in January 2005

Is There an Ideal Way to Combine Trastuzumab With Chemotherapy? ⬇️

scientific article published on October 31, 2011

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

scientific article

Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma

scientific article published in July 2004

Local-Regional Recurrence With and Without Radiation Therapy After Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3N0 Breast Cancer

scientific article published on 30 August 2011

Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy ⬇️

scientific article published on May 23, 2012

Locoregional Interaction of Ixabepilone (Ixempra) After Breast Cancer Radiation ⬇️

scientific article published on February 12, 2013

Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience

scientific article published on 14 August 2006

Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.

scientific article

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes

scientific article

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors ⬇️

scientific article published on November 28, 2011

Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer

scientific article

Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

scientific article

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection

scientific article published on 01 August 2007

MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition

scientific article published on 19 March 2012

Mesothelin expression and survival outcomes in triple receptor negative breast cancer

scientific article published on 27 June 2013

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers ⬇️

scientific article published on February 18, 2011

Metformin and Hepatic Carcinogenesis ⬇️

scientific article published on March 31, 2012

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

scientific article

Metformin: a therapeutic opportunity in breast cancer

scientific article

Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling.

scientific article

Multifocal breast cancer in women < or =35 years old

scientific article published on 01 October 2007

Multifocality and multicentricity in breast cancer and survival outcomes.

scientific article

Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.

scientific article

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

scientific article published on 27 April 2012

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer ⬇️

scientific article published on May 23, 2011

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer

scientific article published on November 2005

Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.

scientific article published on 14 November 2011

Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†.

scientific article

Optimal schedule of paclitaxel: weekly is better

scientific article published on 01 April 2008

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

scientific article

Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy

scientific article published on June 2015

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study

scientific article

Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma

scientific article published on 01 November 2007

Overview of resistance to systemic therapy in patients with breast cancer

scientific article

P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.

scientific article

PD-L1 expression in triple-negative breast cancer

scientific article published on 10 January 2014

PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase

scientific article published on 9 March 2010

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.

scientific article

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer

scientific article

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors ⬇️

scientific article published on March 15, 2012

Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer

scientific article published in October 2004

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience

scientific article published in February 2004

Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity

scientific article

Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer ⬇️

scientific article published on 05 April 2013

Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer

scientific article

Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation

scientific article published on April 2009

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

scientific article published on 12 August 2015

Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer

scientific article

Pharmacodynamic markers of perifosine efficacy

scientific article published on December 2007

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with

scientific article published on 01 March 2010

Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer

scientific article published on 28 September 2012

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer

scientific article

Phase II study of gefitinib in patients with advanced salivary gland cancers

scientific article published on 30 March 2015

Phase II trial of 10-EDAM in the treatment of metastatic breast cancer

scientific article published on 29 September 2006

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

scientific article published on 05 July 2019

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer ⬇️

scientific article published on February 13, 2012

Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy

scientific article

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer

scientific article

Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy

scientific article

Primary angiosarcomas of the breast

scientific article

Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature

scientific article

Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer ⬇️

scientific article published on June 28, 2011

Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution review

scientific article

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

scientific article published on 12 July 2009

Prognostic significance of HER-2 status in women with inflammatory breast cancer

scientific article published on May 2008

Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma

scientific article published on 01 September 2004

Prognostic value of body mass index in locally advanced breast cancer

scientific article published in March 2008

Prognostic value of initial clinical disease stage after achieving pathological complete response

scientific article published on 01 January 2008

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

scientific article published in March 2006

Progress in the biological understanding and management of breast cancer-associated central nervous system metastases

scientific article

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

scientific article

Quantitative proteomic analysis in breast cancer

scientific article published on 01 February 2011

Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer

scientific article

Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.

scientific article published on 2 October 2014

Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.

scientific article

Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer

scientific journal article

Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy

scientific article published on 14 August 2015

Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.

scientific article published in September 2008

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome

scientific article published on 01 July 2007

Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer

scientific article published on 17 July 2014

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

scientific article published on 4 February 2008

Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancer.

scientific article

Role of HGF/MET axis in resistance of lung cancer to contemporary management

scientific article

SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer

scientific article

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

scientific article published on 15 August 2017

Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer

scientific article

Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment ⬇️

scientific article published on January 14, 2011

Staging of breast cancer in the neoadjuvant setting

scientific article published on August 2008

Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma

scientific article published on 28 August 2013

Survival among women with triple receptor-negative breast cancer and brain metastases

scientific article published on 15 January 2009

Survival of women with inflammatory breast cancer: a large population-based study

scientific article published on 24 March 2014

Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline

scientific article published on 05 May 2014

Tamoxifen therapy for patients with breast cancer

scientific article published in June 2013

Targeted therapies: peaking beneath the surface of recent bevacizumab trials

scientific article published on 19 April 2011

Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy ⬇️

scientific article published on August 6, 2012

Targeting the PI3K signaling pathway in cancer therapy ⬇️

scientific article published on January 12, 2012

Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer ⬇️

scientific article published on March 15, 2011

Targeting the mTOR signaling network for cancer therapy

scientific article

The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.

scientific article

The importance of accuracy in HER2 testing

scientific article published on August 1, 2012

The prognostic impact of age in patients with triple-negative breast cancer

scientific article published on 5 March 2013

The role of chemotherapy in colon cancer ⬇️

scientific article published on January 1, 2002

The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy

scientific article published on 01 September 2006

The use of bevacizumab among women with metastatic breast cancer: a survey on clinical practice and the ongoing controversy

scientific article published on 5 October 2011

To biopsy or not to biopsy: is that the only question?

scientific article published on 20 January 2012

Trastuzumab administration associated with change in HER2 status

scientific article published on 01 August 2008

Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome

scientific article

Trends for Inflammatory Breast Cancer: Is Survival Improving?

scientific article published on 01 August 2007

Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer

scientific article published on 25 August 2008

Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes

scientific article published in December 2008

Triple-negative breast cancer is not a contraindication for breast conservation

scientific article

Triple-negative breast cancer: what the radiologist needs to know

scientific article published on January 2011

Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer

scientific article published on 6 December 2011

Two birds with one stone: octreotide treatment for acromegaly and breast cancer

scientific article published on 24 June 2013

Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes

scientific article published on 10 August 2013

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

scientific article

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

scientific article

Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer

scientific article

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor‐positive, HER2‐normal, grade II, lymph node‐negative breast cancers ⬇️

scientific article published on November 15, 2010

Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases

scientific article published on 18 May 2015

Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy

scientific article

Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial

scientific article

Women age < or = 35 years with primary breast carcinoma: disease features at presentation

scientific article published in June 2005

ZNF668 Functions as a Tumor Suppressor by Regulating p53 Stability and Function in Breast Cancer ⬇️

scientific article published on August 18, 2011

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer

scientific article

cMET and phospho-cMET protein levels in breast cancers and survival outcomes

scientific article published on 28 February 2012

eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling

scientific article published on July 2008

p53 expression as a prognostic marker in inflammatory breast cancer

scientific article published on 01 September 2004

Paulina is supported by:

About Paulina

Help